Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueInventory Average

RedHill Biopharma (RDHL) Debt Ratio (2020 - 2022)

Historic Debt Ratio for RedHill Biopharma (RDHL) over the last 3 years, with Q4 2022 value amounting to 1.45.

  • RedHill Biopharma's Debt Ratio rose 21428.25% to 1.45 in Q4 2022 from the same period last year, while for Dec 2022 it was 1.45, marking a year-over-year increase of 21428.25%. This contributed to the annual value of 1.45 for FY2022, which is 21428.25% up from last year.
  • According to the latest figures from Q4 2022, RedHill Biopharma's Debt Ratio is 1.45, which was up 21428.25% from 0.72 recorded in Q3 2022.
  • Over the past 5 years, RedHill Biopharma's Debt Ratio peaked at 1.45 during Q4 2022, and registered a low of 0.37 during Q1 2021.
  • Moreover, its 3-year median value for Debt Ratio was 0.48 (2020), whereas its average is 0.57.
  • As far as peak fluctuations go, RedHill Biopharma's Debt Ratio tumbled by 3118.33% in 2021, and later skyrocketed by 21428.25% in 2022.
  • RedHill Biopharma's Debt Ratio (Quarter) stood at 0.45 in 2020, then increased by 2.21% to 0.46 in 2021, then surged by 214.28% to 1.45 in 2022.
  • Its Debt Ratio was 1.45 in Q4 2022, compared to 0.72 in Q3 2022 and 0.51 in Q2 2022.